THIRD HARMONIC BIO INC's ticker is and the CUSIP is 88427A107. A total of 41 filers reported holding THIRD HARMONIC BIO INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $759,000 | – | 40,000 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atlas Venture Life Science Advisors, LLC | 10,907,859 | $206,922,000 | 22.84% |
| Bain Capital Life Sciences Investors, LLC | 2,280,082 | $43,253,000 | 5.16% |
| COMMODORE CAPITAL LP | 1,018,569 | $19,322,000 | 3.11% |
| BVF INC/IL | 3,501,814 | $66,429,000 | 2.74% |
| Orbimed Advisors | 5,779,071 | $109,629,000 | 2.04% |
| RA Capital Management | 3,475,687 | $65,934,000 | 1.41% |
| Deep Track Capital, LP | 1,268,220 | $24,058,000 | 1.10% |
| GENERAL ATLANTIC, L.P. | 2,958,762 | $56,128,000 | 0.66% |
| Boxer Capital, LLC | 570,417 | $10,821,000 | 0.61% |
| Monashee Investment Management LLC | 40,000 | $759,000 | 0.28% |